Stockscreener 앱 받기
54.68
2.44%
-1.37
시간 외 거래:
55.00
0.32
+0.59%
Biomarin Pharmaceutical Inc (BMRN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
29.17%
989.71
|
766.21 | 874.57 | 776.13 | 825.41 |
| Cost Of Revenue |
4.00%
202.79
|
195.00 | 275.71 | 140.09 | 150.09 |
Selling, General, and Administrative
|
53.14%
395.55
|
258.29 | - | - | - |
| Interest Income/Expense |
534.50%
60.73
|
9.571 | - | - | - |
| Costs And Expenses |
38.05%
878.79
|
636.57 | 919.17 | 822.83 | 548.52 |
| Operating Income/Loss |
14.44%
110.92
|
129.64 | -44.61 | -46.69 | 276.89 |
| Income/Loss From Continuing Operations Before Tax |
56.53%
61.38
|
141.20 | -27.15 | -26.32 | 297.87 |
| Income Tax Expense/Benefit, Deferred |
175.48%
-6.959
|
9.22 | 0.613 | -13.65 | 33.34 |
| Income Tax Expense/Benefit |
53.41%
16.62
|
35.68 | 19.42 | 4.42 | 57.34 |
|
Net Income/Loss
|
57.58%
44.76
|
105.53 | -46.57 | -30.74 | 240.53 |
| Basic Average Shares |
0.48%
193.42
|
192.50 | 0.148 | 192.03 | 191.91 |
| Diluted Average Shares |
1.62%
194.47
|
197.67 | 0.501 | 192.03 | 197.09 |
| Basic Earnings Per Share |
58.18%
0.23
|
0.55 | -0.24 | -0.16 | 1.25 |
| Diluted Earnings Per Share |
57.41%
0.23
|
0.54 | -0.24 | -0.16 | 1.23 |
2.19%
0.07%
자본화:
|
볼륨(24시간):